1.98

2.46% -0.05

After Hours: 1.90 -0.08 -4.04%

Hcw Biologics Inc (HCWB)

Overview News Price History Financials Discussions Forecast

Hcw Biologics Inc stock is traded at $1.98, with a volume of 13,055. It is down -2.46% in the last 24 hours and down -40.18% over the past month. HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Previous Close:

$2.03

Open:

$2.0508

24h Volume:

13,055

Relative Volume:

0.03

Market Cap:

$5.35M

Revenue:

$832.80K

Net Income/Loss:

$-21.55M

P/E Ratio:

-0.1644

EPS:

-12.0465

Net Cash Flow:

$-12.71M

1W Performance:

-6.60%

1M Performance:

-40.18%

6M Performance:

-66.72%

1Y Performance:

-88.21%

1-Day Range:

$1.95

$2.11

1-Week Range:

$1.95

$2.17

52-Week Range:

$1.8401

$41.20

Hcw Biologics Inc Stock (HCWB) Company Profile

Name

Hcw Biologics Inc

Sector

Healthcare (1133)

Industry

Biotechnology (634)

Phone

954-842-2024

Address

2929 N COMMERCE PKWY, MIRAMAR

Employee

Twitter

Next Earnings Date

2025-04-01

Latest SEC Filings

HCWB's Discussions on Twitter

Compare HCWB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCWB Hcw Biologics Inc	1.98	5.51M	832.80K	-21.55M	-12.71M	-12.05
VRTX Vertex Pharmaceuticals Inc	455.48	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	718.36	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	458.12	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	901.17	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.00	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Hcw Biologics Inc Stock (HCWB) Latest News

Dec 04, 2025

Will HCW Biologics Inc. stock benefit from sector rotationJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser

Dec 04, 2025

Dec 02, 2025

HCW Biologics Amends License Agreement with Trimmune - MSN

Dec 02, 2025

How HCW Biologics Inc. stock performs in rate cut cyclesQuarterly Earnings Report & Real-Time Volume Analysis - Newser

Dec 02, 2025

HCW Biologics (NASDAQ:HCWB) Trading Down 7.1% – Here’s What Happened - Defense World

Dec 02, 2025

Dec 01, 2025

HCW Biologics (HCWB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 01, 2025

Nov 28, 2025

Hedge Fund Bets: Why HCW Biologics Inc. stock is seen as undervaluedPortfolio Growth Summary & Weekly Chart Analysis and Guides - BỘ NỘI VỤ

Nov 28, 2025

Nov 27, 2025

Form 8-KCurrent report - ADVFN

Nov 27, 2025

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Nov 27, 2025

HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results - ADVFN

Nov 27, 2025

Nov 23, 2025